secwatch / observer
8-K filed May 7, 2025, 7:59 PM ET ticker CRL CIK 0001100682
other material confidence high sentiment positive materiality 0.75

CRL enters cooperation with Elliott, adds 4 directors, launches strategic review

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul Graves

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Appointed

Abe Ceesay

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Appointed

Steven Barg

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Departed

George E. Massaro

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
Departed

Deborah T. Kochevar

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
Appointed

Mark Enyedy

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Departed

Robert Bertolini

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
Departed

Richard F. Wallman

Director
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Graves was elected as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
elected
Role
Director
Exact text from the filing
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Abe Ceesay was elected as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
elected
Role
Director
Exact text from the filing
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Barg was elected as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
elected
Role
Director
Exact text from the filing
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

George E. Massaro departed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
not stand for re-election
Role
Director
Exact text from the filing
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Deborah T. Kochevar departed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
not stand for re-election
Role
Director
Exact text from the filing
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Enyedy was elected as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
elected
Role
Director
Exact text from the filing
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Bertolini departed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
not stand for re-election
Role
Director
Exact text from the filing
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard F. Wallman departed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action
not stand for re-election
Role
Director
Exact text from the filing
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
View on SEC.gov

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filing history →

Source: SEC EDGAR
accession 0000950103-25-005798
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.